NCT06044363 is a NA clinical trial of Satir group in Drug Abuse, sponsored by Hong Kong Metropolitan University.

Who is sponsoring NCT06044363?

NCT06044363 is sponsored by Hong Kong Metropolitan University.

What drugs are being tested in NCT06044363?

Interventions in NCT06044363: Satir group.

What condition does NCT06044363 study?

NCT06044363 studies Drug Abuse, Self Esteem, Mental Health Wellness 1, Family Dysfunction.

Is NCT06044363 still recruiting?

NCT06044363 is currently completed. Last updated 23 October 2023.

Last reviewed 2023-10-23 · How we verify

NCT06044363

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Satir Model for Self-esteem, Mental Health, and Family Function Among Individuals With Substance Use Disorders

Completed NA Last updated 23 October 2023

What this trial tests

NA trial testing Satir group in Drug Abuse in 45 participants. Completed in 30 September 2023.

Timeline

1 September 2023

Primary endpoint
9 September 2023

30 September 2023

Quick facts

Lead sponsor	Hong Kong Metropolitan University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	45
Start date	1 September 2023
Primary completion	9 September 2023
Estimated completion	30 September 2023
Sites	1 location across China

Drugs / interventions tested

Satir group

Conditions studied

Drug Abuse — all drugs for Drug Abuse →
Self Esteem — all drugs for Self Esteem →
Mental Health Wellness 1 — all drugs for Mental Health Wellness 1 →
Family Dysfunction — all drugs for Family Dysfunction →

Sponsor

Hong Kong Metropolitan University

Who can join

18 and older, any sex, with Drug Abuse or Self Esteem. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Self-esteem and family functioning are associated with mental health and success of drug treatment among individuals with substance use disorders (SUD). The Satir model aims to empower individuals to explore their internal resources, address emotional issues, shift coping strategies, enhancing self-esteem, and develop healthier ways of relating to themselves and others. It offers a range of techniques to enhance self-esteem, challenging negative belief systems, and promote personal growth. The aim of the study is to investigate the acceptability and preliminary efficacy of the Satir model on self-esteem, mental health, and family function among individuals with SUD in China. The study will adopt a mixed-method approach. The quantitative phase will employ a randomized control trial (RCT) utilizing a pre-post study design. The qualitative phase will involve conducting semi-structured individual interviews.The data will be analyzed by using SPSS software package (IBM SPSS statistics version 26.0). The individual-interview will be analyzed by using the six-phase thematic analysis. The study has the potential to advance knowledge in the field of drug rehabilitation interventions, inform evidence-based practice, and improve the wellbeing and outcomes of individual with SUD. It can contribute to the ongoing efforts to address the complex challenges associated with substance use and support individual on their trajectory to recovery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Drug Abuse

Currently open trials in the same condition.

NCT06134882 — OUD Smartphone Services · NA · active not recruiting
NCT05918601 — Peer-led Personalized Support Program · NA · recruiting
NCT05818384 — Wakaya: Rising Up for Choctaw Youth Health · NA · recruiting
NCT05877742 — AA on Drug Abusers by Nursing Students · NA · recruiting
NCT04822987 — Factors Predicting Outcome in Group Treatment of Alcohol Use Disorders (AUDs) · active not recruiting

Other Hong Kong Metropolitan University trials

Trials by the same sponsor.

NCT07458997 — Usability Evaluation of Gen AI-based Nutrition Chatbot for Pregnant Women · NA · not yet recruiting
NCT07527455 — Inhaler Training to Enhance Nurses' Competency in Patient Inhaler Education · NA · not yet recruiting
NCT07494292 — Personalised Active Self-management of Sleep Apnea Program · NA · not yet recruiting
NCT07503535 — Mindful Simulation Training in Palliative Care Education for Nursing Students · NA · active not recruiting
NCT07372872 — Feasibility Testing of the "MyGlucoCare" Smartphone App for Women With Gestational Diabetes · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06044363 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hong Kong Metropolitan University
Last refreshed: 23 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06044363.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing